#toolittletoolate: JUUL-related content on Instagram before and after self-regulatory action.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 15 11 2019
accepted: 03 05 2020
entrez: 22 5 2020
pubmed: 22 5 2020
medline: 13 8 2020
Statut: epublish

Résumé

Digital e-cigarette marketing is largely unregulated and remains easily accessible to young people. The growing public concern around youth JUUL use and its viral presence on social media led the company to engage in several voluntary actions to remove and reduce JUUL-related content on Instagram in May 2018. The current study examined how JUUL-related Instagram content changed in the US following JUUL Labs' wave of voluntary actions in May 2018. In 2019, we collected a total of 50,817 JUUL-relevant posts by 16,323 unique users on Instagram from March 1-May 15, 2018 (Phase 1) and May 16-November 11, 2018 (Phase II) using the application programming interface. We conducted a semantic network analysis to identify major topic clusters over time. Approximately 14,838 JUUL-related posts were made by 5,201 accounts in Phase I and 35,979 posts were made by 11,122 accounts in Phase II. Major content clusters remained unchanged over time-key topics were JUUL-related product characteristics and JUUL-communities; the general vape community; and cannabis-related behavior. Of note, cannabis-related content grew in Phase II, particularly use of the term CBD. Our results reflect the limits of voluntary industry actions to reduce or change vaping-related content on social media. Rather, strong federal restriction on commercial tobacco marketing is the optimal pathway to reduce initial product marketing exposure among youth. These limits would make the emergence and viral contagion of brand-related social media content less likely and reduce its influence on youth behavior.

Identifiants

pubmed: 32437397
doi: 10.1371/journal.pone.0233419
pii: PONE-D-19-31839
pmc: PMC7241740
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0233419

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Med Internet Res. 2016 Mar 18;18(3):e67
pubmed: 26993213
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
Health Commun. 2006;20(1):1-11
pubmed: 16813484
PLoS One. 2016 Jul 13;11(7):e0157304
pubmed: 27410031
Prev Med Rep. 2018 Nov 29;13:93-97
pubmed: 30568866
Subst Use Misuse. 2016 Oct 14;51(12):1669-1673
pubmed: 27484191
Drug Alcohol Depend. 2014 Sep 1;142:168-73
pubmed: 24999061
Tob Control. 2012 Mar;21(2):139-44
pubmed: 22345236
MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277
pubmed: 30439875
Digit Health. 2017 May 23;3:2055207617710802
pubmed: 29942600
Prev Med. 2019 Sep;126:105775
pubmed: 31323286
Tob Control. 2012 Mar;21(2):147-53
pubmed: 22345238
JAMA Pediatr. 2019 Jul 1;173(7):690-692
pubmed: 31107511
Tob Control. 2019 Jul 2;:
pubmed: 31266903

Auteurs

Lauren Czaplicki (L)

Schroeder Institute at Truth Initiative, Washington, DC, United States of America.

Shreya Tulsiani (S)

Schroeder Institute at Truth Initiative, Washington, DC, United States of America.

Ganna Kostygina (G)

Social Data Collaboratory, NORC at the University of Chicago, Chicago, IL, United States of America.

Miao Feng (M)

Social Data Collaboratory, NORC at the University of Chicago, Chicago, IL, United States of America.

Yoonsang Kim (Y)

Social Data Collaboratory, NORC at the University of Chicago, Chicago, IL, United States of America.

Siobhan N Perks (SN)

Schroeder Institute at Truth Initiative, Washington, DC, United States of America.

Sherry Emery (S)

Social Data Collaboratory, NORC at the University of Chicago, Chicago, IL, United States of America.

Barbara Schillo (B)

Schroeder Institute at Truth Initiative, Washington, DC, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH